Diagnostic Approach to Anemia

Clinical Evaluation and Diagnosis of Anemia Introduction: The Diagnostic Approach The evaluation of anemia follows a logical sequence: first, you confirm that anemia is present, then you assess its severity to determine if treatment is needed, and finally, you identify the underlying cause to guide definitive management. This systematic approach ensures that patients receive appropriate, timely care while avoiding unnecessary interventions. Confirming Anemia: Hemoglobin Thresholds Before treating anemia, you must first confirm it exists using hemoglobin concentration cutoffs that vary by population: Men: Anemia is defined as hemoglobin < 130 g/L (< 13 g/dL) Non-pregnant women: Anemia is defined as hemoglobin < 120 g/L (< 12 g/dL) Pregnant women: Anemia is defined as hemoglobin < 105–110 g/L (< 10.5–11 g/dL) These different thresholds reflect physiologic differences; for example, pregnant women have expanded blood volume, so lower absolute hemoglobin values can still provide adequate oxygen delivery. Assessing Severity: Transfusion Thresholds Determining when to transfuse is critical—transfusion carries risks including infection, immune reactions, and fluid overload. Modern practice uses restrictive transfusion strategies based on clinical context: In asymptomatic patients without coronary artery disease: Transfusion is generally not recommended until hemoglobin falls below 60–80 g/L (6–8 g/dL). The body can often compensate for moderate anemia through increased heart rate and breathing. In patients with coronary artery disease (but not actively bleeding): Transfusion is usually considered when hemoglobin is below 70–80 g/L (7–8 g/dL). These patients have compromised cardiac blood flow, so they tolerate anemia less well. The key principle: transfuse only when necessary to prevent tissue hypoxia, not simply to achieve a "normal" hemoglobin value. Initial Laboratory Evaluation: The Complete Blood Count Once anemia is confirmed, the next step is to obtain a complete blood count (CBC) with red-cell indices. This test provides: Hemoglobin concentration and hematocrit: Confirm the degree of anemia Red blood cell (RBC) count: Total number of circulating RBCs Mean corpuscular volume (MCV): The average size of red blood cells The CBC is crucial because the MCV helps classify anemias into three categories: Microcytic (MCV < 80 fL): Small RBCs Normocytic (MCV 80–100 fL): Normal-sized RBCs Macrocytic (MCV > 100 fL): Large RBCs This classification immediately narrows the differential diagnosis. Assessing Bone Marrow Response: Reticulocyte Count The reticulocyte count measures the percentage of young, immature RBCs in circulation. Young RBCs contain residual ribosomes that are visible on special staining—these are reticulocytes. The count is critical because it tells you whether the bone marrow is responding appropriately to anemia. Why this matters: A healthy marrow should increase RBC production when hemoglobin drops. A low or normal reticulocyte count in an anemic patient suggests the marrow is failing to respond—this indicates bone marrow dysfunction rather than simple blood loss or hemolysis. To account for the degree of anemia, calculate the reticulocyte production index: $$\text{Reticulocyte Production Index} = \text{(Reticulocyte \% )} \times \frac{\text{Patient's hematocrit}}{\text{Normal hematocrit}} \times \frac{1}{\text{Maturation time}}$$ A production index > 2 indicates adequate marrow response (the marrow is "trying"); a value < 1 suggests marrow failure. Identifying the Cause: Iron Studies If anemia is microcytic (small RBCs), iron studies are the next essential tests. These three tests work together: Serum ferritin: Reflects total iron stores; low ferritin (< 30 ng/mL) indicates depleted iron stores and suggests iron-deficiency anemia Serum iron: The circulating iron level; typically low in iron deficiency Transferrin saturation: The percentage of transferrin (iron transport protein) that is carrying iron; typically low in iron deficiency (< 20%) Total iron-binding capacity (TIBC): Indirect measure of transferrin; typically elevated in iron deficiency because the body upregulates iron transport proteins when iron is scarce A critical distinction: The combination of elevated ferritin with low transferrin saturation suggests anemia of chronic disease, not iron deficiency. In chronic disease states (infection, inflammation, malignancy), iron is sequestered in tissues despite adequate total stores, so ferritin rises but iron availability falls. Identifying the Cause: Vitamin B12 and Folate Deficiency If anemia is macrocytic (large RBCs), measure serum vitamin B12 and red blood cell (RBC) folate levels to identify megaloblastic anemias. These vitamins are essential for DNA synthesis; their deficiency causes impaired RBC production and production of abnormally large, immature cells (megaloblasts). Low B12 + low folate: Combined deficiency (common in severe malnutrition) Low B12 alone: Suggests pernicious anemia, dietary deficiency, or malabsorption Low folate alone: Often due to inadequate intake, alcoholism, or certain medications The Mentzer Index: Distinguishing Iron Deficiency from Thalassemia A particularly useful calculation for microcytic anemias is the Mentzer index, which helps distinguish iron-deficiency anemia from thalassemia trait: $$\text{Mentzer Index} = \frac{\text{MCV}}{\text{RBC count}}$$ Mentzer Index < 13: Suggests thalassemia trait (many small RBCs) Mentzer Index > 13: Suggests iron-deficiency anemia This distinction is important because the treatments differ: iron supplementation helps iron deficiency but is unnecessary (and can be harmful) in thalassemia. Morphologic Clues: Peripheral Blood Smear Microscopic examination of a peripheral blood smear provides direct visual information about RBC morphology and can reveal specific causes: What to look for: Microcytosis (small cells): Suggests iron deficiency, thalassemia, or chronic disease Macrocytosis (large cells): Suggests B12 or folate deficiency Basophilic stippling (visible remnants of ribosomes): Seen in thalassemia and lead poisoning Schistocytes (fragmented cells): Indicate mechanical destruction, suggesting microangiopathic hemolytic anemia Hypersegmented neutrophils (> 5 nuclear lobes): Characteristic of megaloblastic anemia from B12 or folate deficiency Sickle cells: Diagnostic of sickle cell disease The smear is particularly valuable when automated counters are unavailable or when results seem inconsistent with clinical presentation. When Marrow Failure Is Suspected: Bone Marrow Examination In most anemia cases, peripheral blood tests and iron/vitamin studies provide sufficient diagnostic information. However, bone marrow aspiration is indicated when: The cause remains unclear after initial testing Marrow failure (aplastic anemia, myelodysplasia) is suspected Malignancy or infection involving the marrow is possible Severe anemia with low reticulocyte production index suggests inadequate marrow response Marrow examination directly visualizes cellularity, allows assessment of erythropoiesis, and can reveal infiltrative diseases or dysplasia not apparent on peripheral smear. Summary: A Systematic Diagnostic Sequence The evaluation of anemia follows this logical order: Confirm anemia using hemoglobin thresholds for the specific population Assess severity and determine if immediate transfusion is needed Obtain CBC with indices to classify by MCV (micro-, normo-, or macrocytic) Check reticulocyte count to assess marrow response Perform targeted tests based on MCV: Microcytic: Iron studies, consider Mentzer index and hemoglobin electrophoresis Macrocytic: B12 and folate levels Normocytic: Reticulocyte count and peripheral smear (suggests hemolysis or acute loss) Order peripheral blood smear if morphologic clues are needed Consider bone marrow exam only if initial tests are inconclusive or marrow failure is suspected This systematic approach identifies the cause efficiently while minimizing unnecessary testing and guiding appropriate treatment.